Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2026-02-05 @ 1:39 AM
Study NCT ID:
NCT05378867
Status:
UNKNOWN
Last Update Posted:
2022-05-18
First Post:
2022-04-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC
Sponsor:
Zhejiang Teruisi Pharmaceutical Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Colorectal Cancer (CRC) | View |
Keywords: